side effects semaglutide for weight loss of Wegovy Explained New Research Uncovers Hidden Side

But stopping the medicine may be the safest choice while doctors learn more about what is happening

The ZENITH phase 3 CVOT (initiated in 2025, enrolling ~ 11,000 patients) will assess 300 mg administered every 6 months versus placebo for MACE (CV death, non-fatal MI, stroke, or HF) in subgroups with uncontrolled hypertension and high CV risk [100]

Recent studies have also explored its potential in reducing pain and inflammation in the digestive tract, indicating its potential as a therapy for inflammatory bowel disease and irritable bowel syndrome

At the moment, we still dont fully understand what is driving it

Ingredients: L-Carnitine tartrate (83,3%)